• 1. Clickable coupling of carboxylic acids and amines at room temperature mediated by SO2F2: a significant breakthrough for the construction of amides and peptide linkages
  Shi-Meng Wang,Chuang Zhao,Xu Zhang,Hua-Li Qin Org. Biomol. Chem. 2019 17 4087
• 2. Discovery of quinolone derivatives as antimycobacterial agents
  Kun-Lin Liu,Fei Teng,Lu Xiong,Xiao Li,Chao Gao,Luo-Ting Yu RSC Adv. 2021 11 24095
• 3. Design, synthesis, and biological evaluation of m-amidophenol derivatives as a new class of antitubercular agents
  Niu-niu Zhang,Zhi-yong Liu,Jie Liang,Yun-xiang Tang,Lu Qian,Ya-min Gao,Tian-yu Zhang,Ming Yan Med. Chem. Commun. 2018 9 1293
• 4. A general and practical oxidation of alcohols to primary amides under metal-free conditions
  Xiao-Feng Wu,Muhammad Sharif,Jian-Bo Feng,Helfried Neumann,Anahit Pews-Davtyan,Peter Langer,Matthias Beller Green Chem. 2013 15 1956
• 5. Rearrangement of aldoximes to amides in water under air atmosphere catalyzed by water-soluble iridium complex [Cp*Ir(H2O)3][OTf]2
  Chunlou Sun,Panpan Qu,Feng Li Catal. Sci. Technol. 2014 4 988

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzamides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzamides

Professional Introduction to 4-(trifluoromethoxy)benzamide (CAS No. 456-71-3)

4-(trifluoromethoxy)benzamide (CAS No. 456-71-3) is a fluorinated aromatic amide that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology due to its unique structural properties and potential biological activities. This compound belongs to a class of molecules that exhibit a high degree of lipophilicity and metabolic stability, making it an attractive scaffold for the development of novel therapeutic agents.

The presence of a trifluoromethoxy group in the molecule imparts enhanced electronic and steric effects, which can significantly influence its interactions with biological targets. The trifluoromethyl moiety, in particular, is known for its ability to modulate the pharmacokinetic profile of drugs by increasing their lipophilicity and reducing their susceptibility to metabolic degradation. These properties have made 4-(trifluoromethoxy)benzamide a valuable intermediate in the synthesis of various pharmacologically active compounds.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors targeting specific enzymes and receptors involved in diseases such as cancer, inflammation, and neurodegeneration. The amide functionality in 4-(trifluoromethoxy)benzamide provides a versatile platform for designing molecules that can interact with proteins through hydrogen bonding and other non-covalent interactions. This has led to the exploration of its potential as an inhibitor of enzymes such as kinases and proteases, which play crucial roles in disease pathogenesis.

One of the most compelling aspects of 4-(trifluoromethoxy)benzamide is its ability to serve as a building block for the synthesis of more complex molecules with tailored biological activities. For instance, researchers have utilized this compound to develop novel benzamide derivatives that exhibit potent anti-inflammatory properties. These derivatives have shown promise in preclinical studies, where they have demonstrated efficacy in models of acute and chronic inflammation by modulating the activity of key inflammatory pathways.

The fluorinated aromatic ring system in 4-(trifluoromethoxy)benzamide also contributes to its stability under various chemical conditions, making it a robust scaffold for drug development. This stability is particularly important for pharmaceuticals that require long-term storage or administration under challenging physiological conditions. Additionally, the presence of the trifluoromethoxy group enhances the compound's solubility in organic solvents, facilitating its use in synthetic protocols and formulation development.

In the realm of medicinal chemistry, 4-(trifluoromethoxy)benzamide has been employed in the design of molecules targeting neurological disorders. Recent studies have highlighted its potential as an antagonist of certain neurotransmitter receptors, which could lead to the development of new treatments for conditions such as epilepsy and Alzheimer's disease. The ability of this compound to cross the blood-brain barrier has been particularly noted, making it a promising candidate for central nervous system (CNS) drug discovery.

The synthesis of 4-(trifluoromethoxy)benzamide typically involves multi-step organic reactions that showcase the compound's versatility as a synthetic intermediate. Common synthetic routes include nucleophilic aromatic substitution reactions followed by amide bond formation. These reactions can be optimized to produce high yields and purity, making them suitable for industrial-scale production. The use of fluorinated reagents and catalysts in these synthetic pathways underscores the importance of fluorine chemistry in modern drug development.

The pharmacological evaluation of 4-(trifluoromethoxy)benzamide has revealed several interesting properties that make it a compelling candidate for further investigation. In vitro studies have demonstrated its ability to inhibit the activity of various enzymes associated with cancer cell proliferation and survival. Additionally, it has shown promise in reducing oxidative stress and inflammation, which are key pathological features in many chronic diseases.

The structural features of 4-(trifluoromethoxy)benzamide, particularly the combination of the trifluoromethoxy group and the benzamide moiety, contribute to its unique pharmacological profile. The trifluoromethoxy group enhances binding affinity by improving hydrophobic interactions with target proteins, while the benzamide moiety provides a hydrogen bond acceptor site that facilitates stable interactions with polar residues on biological targets. This synergistic effect has led to the discovery of several novel drug candidates with improved efficacy and selectivity.

In conclusion, 4-(trifluoromethoxy)benzamide(CAS No. 456-71-3) is a multifaceted compound with significant potential in pharmaceutical research and drug development. Its unique structural features make it an excellent scaffold for designing molecules with tailored biological activities targeting various diseases. The ongoing research into this compound underscores its importance as a building block for innovative therapeutic agents and highlights its role in advancing our understanding of fluorinated aromatic chemistry.

• 658-91-3(3-(trifluoromethoxy)benzamide)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)